Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study
Titel:
Biweekly docetaxel and gemcitabine as neoadjuvant chemotherapy followed by adjuvant doxorubicin and cyclophosphamide therapy in stage II and III breast cancer patients: results of a phase II study
Auteur:
Estévez, L. G. Sánchez-Rovira, P. Dómine, M. León, A. Calvo, I. Jaén, A. Casado, V. Rubio, G. Díaz, M. Miró, C. Lobo, F. Carrasco, E. Casillas, M. San Antonio, B.